BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 9554527)

  • 21. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
    Anagnostopoulos A; Aleman A; Ayers G; Donato M; Champlin R; Weber D; Alexanian R; Giralt S
    Cancer; 2004 Jun; 100(12):2607-12. PubMed ID: 15197803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid arthropathy in the course of multiple myeloma.
    Fautrel B; Fermand JP; Sibilia J; Nochy D; Rousselin B; Ravaud P
    J Rheumatol; 2002 Jul; 29(7):1473-81. PubMed ID: 12136908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
    Perfetti V; Siena S; Palladini G; Bregni M; Di Nicola M; Obici L; Magni M; Brunetti L; Gianni AM; Merlini G
    Haematologica; 2006 Dec; 91(12):1635-43. PubMed ID: 17145600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.
    Riccardi A; Mora O; Tinelli C; Valentini D; Brugnatelli S; Spanedda R; De Paoli A; Barbarano L; Di Stasi M; Giordano M; Delfini C; Nicoletti G; Bergonzi C; Rinaldi E; Piccinini L; Ascari E
    Br J Cancer; 2000 Apr; 82(7):1254-60. PubMed ID: 10755397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].
    Adam Z; Stork M; Pour L; Krejčí M; Zahradová L; Sandecká V; Hájek R; Cermáková Z; Pospíšilová Y; Navrátil M; Král Z; Mayer J
    Vnitr Lek; 2012 Dec; 58(12):896-903. PubMed ID: 23427947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid in bone marrow smears of patients affected by multiple myeloma.
    Petruzziello F; Zeppa P; Catalano L; Cozzolino I; Gargiulo G; Musto P; D'Auria F; Liso V; Rizzi R; Caruso N; Califano C; Piro E; Musso M; Bonanno V; Pia Falcone A; Tafuto S; Di Raimondo F; De Laurentiis M; Pane F; Palombini L; Rotoli B
    Ann Hematol; 2010 May; 89(5):469-74. PubMed ID: 19894050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
    Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
    Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodular amyloidosis: review and long-term follow-up of 16 cases.
    Moon AO; Calamia KT; Walsh JS
    Arch Dermatol; 2003 Sep; 139(9):1157-9. PubMed ID: 12975157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapidly progressive glomerulonephritis complicating primary AL amyloidosis and multiple myeloma.
    Crosthwaite A; Skene A; Mount P
    Nephrol Dial Transplant; 2010 Aug; 25(8):2786-9. PubMed ID: 20042399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
    Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno NT; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R
    Bone Marrow Transplant; 2002 Sep; 30(6):367-73. PubMed ID: 12235521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA; Mueller PS; Kyle RA; Larson DR; Plevak MF; Gertz MA
    Medicine (Baltimore); 2003 Sep; 82(5):291-8. PubMed ID: 14530778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical images: Skeletal muscle pseudo-hypertrophy in myeloma-associated amyloidosis.
    Lawson TM; Bevan MA; Williams BD
    Arthritis Rheum; 2002 Aug; 46(8):2251. PubMed ID: 12209535
    [No Abstract]   [Full Text] [Related]  

  • 40. Localized amyloidosis: a survey of 35 French cases.
    Paccalin M; Hachulla E; Cazalet C; Tricot L; Carreiro M; Rubi M; Grateau G; Roblot P
    Amyloid; 2005 Dec; 12(4):239-45. PubMed ID: 16399649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.